Nerivio, FGD000075-4.7

Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine

Theranica Bioelectronics Ltd

The following data is part of a premarket notification filed by Theranica Bioelectronics Ltd with the FDA for Nerivio, Fgd000075-4.7.

Pre-market Notification Details

Device IDK203181
510k NumberK203181
Device Name:Nerivio, FGD000075-4.7
ClassificationDistal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine
Applicant Theranica Bioelectronics Ltd 4 Ha-Omanutst. Poleg Industrial Park Netanya,  IL 4250574
ContactAlon Ironi
CorrespondentJanice M. Hogan
Hogan Lovells US LLP 1735 Market Street Suite 2300 Philadelphia,  PA  19103
Product CodeQGT  
CFR Regulation Number882.5899 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2020-10-26
Decision Date2021-01-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.